Weiming Luo

2.2k total citations
49 papers, 1.8k citations indexed

About

Weiming Luo is a scholar working on Molecular Biology, Organic Chemistry and Neurology. According to data from OpenAlex, Weiming Luo has authored 49 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Organic Chemistry and 10 papers in Neurology. Recurrent topics in Weiming Luo's work include Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Multiple Myeloma Research and Treatments (7 papers). Weiming Luo is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Multiple Myeloma Research and Treatments (7 papers). Weiming Luo collaborates with scholars based in United States, China and Taiwan. Weiming Luo's co-authors include Nigel H. Greig, David Tweedie, Harold W. Holloway, Barry J. Hoffer, Susanna Rosi, Qian‐sheng Yu, Yazhou Li, Karim Bélarbi, Carla Arellano and Timothy Jopson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hazardous Materials and Scientific Reports.

In The Last Decade

Weiming Luo

42 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiming Luo United States 21 631 585 367 315 265 49 1.8k
Sidharth Mehan India 29 1.0k 1.6× 387 0.7× 324 0.9× 326 1.0× 466 1.8× 123 2.5k
François Mouton‐Liger France 31 987 1.6× 346 0.6× 859 2.3× 365 1.2× 190 0.7× 78 2.3k
Ying Peng China 32 916 1.5× 1.3k 2.2× 910 2.5× 347 1.1× 343 1.3× 76 3.1k
Yasuhiko Izumi Japan 31 1.1k 1.7× 378 0.6× 414 1.1× 454 1.4× 295 1.1× 82 2.3k
Yam Nath Paudel Malaysia 27 793 1.3× 521 0.9× 397 1.1× 300 1.0× 181 0.7× 60 2.3k
Zhihou Liang China 25 912 1.4× 417 0.7× 1.0k 2.7× 327 1.0× 265 1.0× 48 2.4k
Chun‐Ling Dai United States 22 741 1.2× 452 0.8× 890 2.4× 78 0.2× 237 0.9× 51 1.9k
Long Tai Zheng China 25 822 1.3× 457 0.8× 188 0.5× 127 0.4× 174 0.7× 64 1.8k
Grzegorz A. Czapski Poland 25 622 1.0× 299 0.5× 478 1.3× 201 0.6× 171 0.6× 56 1.7k
Rita Valenzuela Spain 25 606 1.0× 253 0.4× 185 0.5× 309 1.0× 343 1.3× 34 1.6k

Countries citing papers authored by Weiming Luo

Since Specialization
Citations

This map shows the geographic impact of Weiming Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiming Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiming Luo more than expected).

Fields of papers citing papers by Weiming Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiming Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiming Luo. The network helps show where Weiming Luo may publish in the future.

Co-authorship network of co-authors of Weiming Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Weiming Luo. A scholar is included among the top collaborators of Weiming Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiming Luo. Weiming Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Weiming, David Tweedie, Cindy H. Chau, et al.. (2025). Monoterpenoid fluorophthalimide IMiDs that lack human cereblon binding: synthesis and anti-proliferative, anti-angiogenic and anti-inflammatory activities. Biochemical and Biophysical Research Communications. 779. 152428–152428.
2.
Chen, Kai‐Yun, Shih‐Chang Hsueh, David Tweedie, et al.. (2025). 3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the rat. GeroScience. 47(4). 5763–5783. 1 indexed citations
3.
Chen, Congcong, et al.. (2025). Unraveling the impact of sulfur species in the FeSx layer on thallium (I) removal by sulfidized nanoscale zero-valent iron. Journal of Hazardous Materials. 495. 139017–139017.
4.
Liu, Xing, et al.. (2025). PPP1CA promotes hepatocellular carcinoma progression in a YAP1-dependent way. Cellular Signalling. 134. 111938–111938.
5.
Zhu, Yu, et al.. (2024). The study of the role of purified anti-mouse CD193 (CCR3) antibody in allergic rhinitis mouse animal models. Scientific Reports. 14(1). 1059–1059. 1 indexed citations
6.
Lecca, Daniela, Shih‐Chang Hsueh, Weiming Luo, et al.. (2023). Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury. Journal of Biomedical Science. 30(1). 16–16. 13 indexed citations
7.
Luo, Weiming, et al.. (2022). Research on the Real-Time Detection Method for Image Processing – Based Civil Structure Crack. Traitement du signal. 39(6). 2223–2228. 5 indexed citations
8.
Peach, Megan L., Shaunna Beedie, Cindy H. Chau, et al.. (2020). Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs. Molecules. 25(23). 5683–5683. 14 indexed citations
9.
Luo, Weiming, David Tweedie, Shaunna Beedie, et al.. (2018). Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-α and angiogenesis inhibitory activities. Bioorganic & Medicinal Chemistry. 26(8). 1547–1559. 16 indexed citations
10.
Wang, Jingya, Ya‐Ni Huang, Chong‐Chi Chiu, et al.. (2016). Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat. Journal of Neuroinflammation. 13(1). 168–168. 40 indexed citations
11.
12.
13.
Greig, Nigel H., et al.. (2011). Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases. CNS & Neurological Disorders - Drug Targets. 10(3). 391–403. 204 indexed citations
14.
Luo, Weiming, Qian-sheng Yu, Harold W. Holloway, et al.. (2011). Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity. Bioorganic & Medicinal Chemistry. 19(13). 3965–3972. 20 indexed citations
15.
Yu, Qian, Harold W. Holloway, Weiming Luo, et al.. (2010). Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. Bioorganic & Medicinal Chemistry. 18(13). 4687–4693. 29 indexed citations
16.
Tweedie, David, Weiming Luo, Ryan G. Short, et al.. (2009). A cellular model of inflammation for identifying TNF-α synthesis inhibitors. Journal of Neuroscience Methods. 183(2). 182–187. 45 indexed citations
17.
Son, Tae Gen, Simonetta Camandola, Thiruma V. Arumugam, et al.. (2009). Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia. Journal of Neurochemistry. 112(5). 1316–1326. 170 indexed citations
18.
Chen, Yaowen, et al.. (2008). A dynamic clonal selection immune clustering algorithm. PubMed. 32. 1048–1051. 2 indexed citations
19.
Kamal, Mohammad Amjad, Weiming Luo, Yazhou Li, et al.. (2007). Kinetics of Human Serum Butyrylcholinesterase Inhibition by a Novel Experimental Alzheimer Therapeutic, Dihydrobenzodioxepine Cymserine. Neurochemical Research. 33(5). 745–753. 63 indexed citations
20.
Greig, Nigel H., Qian‐sheng Yu, Weiming Luo, et al.. (2003). Racemic N1-Norphenserine and Its Enantiomers: Unpredicted Inhibition of Human Acetyl- and Butyrylcholinesterase and β-Amyloid Precursor Protein in vitro. Heterocycles. 61(1). 529–529. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sidharth Mehan Breakdown of academic impact, for papers by François Mouton‐Liger Breakdown of academic impact, for papers by Ying Peng Breakdown of academic impact, for papers by Yasuhiko Izumi Breakdown of academic impact, for papers by Yam Nath Paudel Breakdown of academic impact, for papers by Zhihou Liang Breakdown of academic impact, for papers by Chun‐Ling Dai Breakdown of academic impact, for papers by Long Tai Zheng Breakdown of academic impact, for papers by Grzegorz A. Czapski Breakdown of academic impact, for papers by Rita Valenzuela
Rankless by CCL
2026